CSL - Ordinary Share Capital


CSL reported $482.13M in Ordinary Share Capital for its fiscal semester ending in December of 2025.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Arca Biopharma USD 50.17M 1.45M Mar/2026
aTyr Pharma USD 62.99M 46.35M Mar/2026
Bio Path USD 9.34M 100K Mar/2026
Brainstorm Cell Therapeutics USD 11.04M 0 Mar/2026
Cara Therapeutics USD 9.38M 2.01K Mar/2026
CSL USD 482.13M 93.87M Dec/2025
Curis USD 2M 10.93M Mar/2026
Immunic USD 120.38M 21.73M Dec/2025
Minerva Neurosciences USD 1000 0 Sep/2024
TherapeuticsMD USD 11K 0 Sep/2023